Alix Marduel Net Worth & Insider Trades

Alix Marduel Corcept Therapeutics Inc

As of November 13, 2008

What is Alix Marduel's Net Worth?

The current estimated net worth of Corcept Therapeutics Inc's Alix Marduel is estimated to be about $58.84M . Alix Marduel owns about 166,491 units of Corcept Therapeutics Inc common stock. In the last 4 years at Corcept Therapeutics Inc, Alix Marduel has sold an estimated value of $0 worth.

What is Alix Marduel's Past Insider Trading?

Alix Marduel's largest purchase order was 1,059,135 units , worth over $2.93M on March 26, 2008. In total, Alix Marduel has made about 7 transactions over 4 years of their time at Corcept Therapeutics Inc. Alix Marduel usually trades in August and April, with the busiest year in 2007.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Alix Marduel's' Mailing Address?

  • Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 - $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 - $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 - $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 - $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 - $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 - $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 - $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 - $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 - $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

What are Corcept Therapeutics Inc's Past Insider Trades?

Corcept Therapeutics Inc's most recent insider trade came on December 6, 2023 by Gary Charles Robb who sold 16,381 units worth $434.84K . In the last 19 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $206.96M and bought an estimated value of $188.83M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director .

CORCEPT THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...